Saudi Arabia Compression Therapy Market Analysis

Saudi Arabia Compression Therapy Market Executive Summary

Saudi Arabia Compression Therapy Market was valued at $65 Mn in 2022 and is estimated to reach $112 Mn in 2030, exhibiting a CAGR of 7.1% during the forecast period.

Compression therapy is a medical procedure commonly utilized on limbs to enhance blood circulation and reduce swelling. It is often employed in the treatment of conditions like lymphedema, venous disorders, and certain types of edemas. The primary objective is to enhance the flow of blood in the veins, facilitating the return of blood to the heart. This helps prevent the accumulation of fluid in the tissues, especially when swelling is a result of fluid retention. Depending on the severity of the condition and the individual's specific needs, compression therapy can take various forms, such as elastic stockings, sleeves, or bandages. Techniques like compression wraps involve the use of multiple layers of bandages to provide graduated compression, while intermittent pneumatic compression (IPC) employs a device to mimic natural muscle contractions, assisting in venous return. To determine the most suitable technique and compression level for a particular case, it is essential to consult with a healthcare provider, especially when developing comprehensive treatment plans for issues like poor circulation, swelling, or fluid retention.

In Saudi adults, the prevalence of chronic venous insufficiency (CVI) is 45.6%, which is higher than rates seen in Western nations. According to gender-specific, the prevalence is higher in females (49.6%), with a higher percentage in the Western region (44.0%). Varicose veins are particularly prevalent, with female nurses leading at 47.6%, followed by teachers at 42%, affecting 37% of women and 14% of men. These high rates are caused by many lifestyle factors, including obesity, prolonged sitting or standing, and decreased physical activity. Genetic predisposition also contributes, with some populations having a higher risk of developing venous disorders. The effects of the climate, particularly in warm areas, aggravate pre-existing vein problems. Inequalities in healthcare access can impede timely diagnosis and treatment, which in turn adds to the observed variations in prevalence among various regions.

The market is witnessing an upsurge in technologically advanced compression garments and devices. Smart socks with built-in sensors, mobile applications-controlled pneumatic compression pumps, and specially designed clothing created using 3D scanning technology are a few notable examples. These innovations bring about enhanced levels of comfort, improved compliance, and personalized experiences for users in the field of compression therapy.

Market Dynamics

Market Growth Drivers

Rising Prevalence of Venous Disorders: The high prevalence of venous disorders like chronic venous insufficiency and varicose veins in Saudi Arabia is fuelling the demand for compression therapy solutions. This increased demand acts as a key driver for the growth of the compression therapy market in the country, addressing the rising health concerns associated with these conditions.

Increased Awareness and Education: Increased awareness and education on venous disorders through public health initiatives are driving growth in the compression therapy market. As people become more informed about the risks and benefits, there is a rising demand for preventative and therapeutic measures, particularly compression therapy.

Technological Advancements: The expansion of the compression therapy market is driven by progress in materials, design, and the integration of smart technology. Breakthroughs such as sensors and intelligent fabrics facilitate real-time pressure monitoring, data gathering, and personalized adjustments, thereby improving the effectiveness of treatment and enhancing the overall user experience. These advancements reflect a dedication to enhancing therapeutic outcomes and user comfort within the realm of compression therapy.

Market Restraints

Patient Compliance: The market for compression therapy is limited by certain clothing items that cause discomfort after prolonged use, which may cause patients to stop using the therapy. One obstacle to compliance is the difficult process of putting on and taking off these garments, particularly for elderly or dexterously challenged individuals. Furthermore, patients may be less motivated to use compression therapy consistently due to its preventive and long-term nature, which would impede its widespread adoption.

Alternative Treatment Options: The availability and preference for alternative treatments in the compression therapy market act as a restraint. If individuals choose other options based on factors like perceived effectiveness or comfort, it hinders the widespread adoption of compression therapy products, limiting market growth.

Cost and Accessibility: The compression therapy market faces limitations due to the expensive nature of custom-made or technologically advanced compression garments. This cost can be a financial obstacle for patients, compounded by the fact that not all compression therapy devices are covered by provincial health insurance plans, placing the full financial burden on individuals. Additionally, the uneven availability of certified medical practitioners, particularly in remote areas, hinders widespread adoption and constrains market growth.

Notable Recent Updates

November 2020, Therabody, a leader in tech wellness, acquired RP Sports, integrating RecoveryPump's clinical technology into its offerings. This marked a significant expansion for Therabody, introducing therapeutic pneumatic compression technology to the public. RecoveryPump, an FDA-approved Class II medical-grade device, is trusted by over 350 sports teams, medical professionals, athletes, and physiotherapists.

Healthcare Policies and Regulatory Landscape

In Saudi Arabia, regulatory agencies and fundamental healthcare policies oversee the management of therapeutic drugs. The Saudi Food and Drug Authority (SFDA), which protects the integrity and safety of medications, is the main regulatory body in charge of this process. The Drug Sector of the Ministry of Health (MOH) oversees the management of pharmaceutical affairs, including drug registration and pricing, while the MOH works with the SFDA to develop healthcare policies. With an emphasis on encouraging responsible drug use and guaranteeing safety, the National Committee for Drug Control (NCDC) is instrumental in organizing efforts related to drug control. The National Pharmacovigilance Centre (NPC) is responsible for monitoring pharmaceutical safety, while the Saudi Central Board for Accreditation of Healthcare Institutions (CBAHI) indirectly influences drug administration through the accreditation of healthcare institutions.

Competitive Landscape

Key Players

• Medi France
• Sigvaris
• Juzo
• Bauerfeind
• Jobst
• Lympha Press
• FLA Orthopedics
• Al-Johaifa Medical
• Nahdi Pharmacy
• AstraZeneca